Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin
Dragomir B. Krastev, Shudong Li, Yilun Sun, et al.
Nature Cell Biology (2022) Vol. 24, Iss. 1, pp. 62-73
Open Access | Times Cited: 110

Showing 1-25 of 110 citing articles:

Targeting DNA damage response pathways in cancer
Florian J. Groelly, Matthew Fawkes, Rebecca A. Dagg, et al.
Nature reviews. Cancer (2022) Vol. 23, Iss. 2, pp. 78-94
Closed Access | Times Cited: 427
Targeted Therapy and Mechanisms of Drug Resistance in Breast Cancer
Briana Kinnel, Santosh Kumar Singh, Gabriela Oprea‐Ilies, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1320-1320
Open Access | Times Cited: 74
Leveraging the replication stress response to optimize cancer therapy
Emily Cybulla, Alessandro Vindigni
Nature reviews. Cancer (2022) Vol. 23, Iss. 1, pp. 6-24
Open Access | Times Cited: 69
Transcription-coupled DNA–protein crosslink repair by CSB and CRL4CSA-mediated degradation
Marjolein van Sluis, Qing Yu, Melanie van der Woude, et al.
Nature Cell Biology (2024) Vol. 26, Iss. 5, pp. 770-783
Open Access | Times Cited: 20
Longitudinal profiling identifies co-occurring BRCA1/2 reversions, TP53BP1, RIF1 and PAXIP1 mutations in PARP inhibitor-resistant advanced breast cancer
Elizabeth Harvey-Jones, Maya Raghunandan, Luisa Robbez‐Masson, et al.
Annals of Oncology (2024) Vol. 35, Iss. 4, pp. 364-380
Open Access | Times Cited: 19
Resistance to DNA repair inhibitors in cancer
Joseph S. Baxter, Diana Zatreanu, Stephen J. Pettitt, et al.
Molecular Oncology (2022) Vol. 16, Iss. 21, pp. 3811-3827
Open Access | Times Cited: 51
Deubiquitinating enzymes and the proteasome regulate preferential sets of ubiquitin substrates
Fredrik Trulsson, Vyacheslav Akimov, Mihaela Robu, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 51
PARP1 proximity proteomics reveals interaction partners at stressed replication forks
Thorsten Mosler, H. Irem Baymaz, Justus F. Gräf, et al.
Nucleic Acids Research (2022) Vol. 50, Iss. 20, pp. 11600-11618
Open Access | Times Cited: 41
NAD+ rescues aging-induced blood-brain barrier damage via the CX43-PARP1 axis
Rui Zhan, Xia Meng, Dongping Tian, et al.
Neuron (2023) Vol. 111, Iss. 22, pp. 3634-3649.e7
Closed Access | Times Cited: 36
Inhibitors of the ATPase p97/VCP: From basic research to clinical applications
Susan Kilgas, Kristijan Ramadan
Cell chemical biology (2023) Vol. 30, Iss. 1, pp. 3-21
Open Access | Times Cited: 31
Mechanism of PARP inhibitor resistance and potential overcoming strategies
Xiaoyu Fu, Ping Li, Qi Zhou, et al.
Genes & Diseases (2023) Vol. 11, Iss. 1, pp. 306-320
Open Access | Times Cited: 26
Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair
Emile Alghoul, Matteo Paloni, Arato Takedachi, et al.
Molecular Cell (2023) Vol. 83, Iss. 10, pp. 1640-1658.e9
Open Access | Times Cited: 24
PARP1 roles in DNA repair and DNA replication: The basi(c)s of PARP inhibitor efficacy and resistance
Petar-Bogomil Kanev, Aleksandar Atemin, Stoyno Stoynov, et al.
Seminars in Oncology (2023) Vol. 51, Iss. 1-2, pp. 2-18
Open Access | Times Cited: 22
ADP-ribose contributions to genome stability and PARP enzyme trapping on sites of DNA damage; paradigm shifts for a coming-of-age modification
Élise Rouleau-Turcotte, John M. Pascal
Journal of Biological Chemistry (2023) Vol. 299, Iss. 12, pp. 105397-105397
Open Access | Times Cited: 22
A unified mechanism for PARP inhibitor-induced PARP1 chromatin retention at DNA damage sites in living cells
Petar-Bogomil Kanev, Sylvia Varhoshkova, Irina Georgieva, et al.
Cell Reports (2024) Vol. 43, Iss. 5, pp. 114234-114234
Open Access | Times Cited: 10
PARPi, BRCA, and gaps: controversies and future research
Diego Dibitetto, Carmen A. Widmer, Sven Rottenberg
Trends in cancer (2024) Vol. 10, Iss. 9, pp. 857-869
Open Access | Times Cited: 10
A two-step mechanism governing PARP1-DNA retention by PARP inhibitors
Huijun Xue, Amit Bhardwaj, Yandong Yin, et al.
Science Advances (2022) Vol. 8, Iss. 36
Open Access | Times Cited: 37
TSG101 associates with PARP1 and is essential for PARylation and DNA damage‐induced NF‐κB activation
Ahmet Buğra Tufan, Katina Lazarow, Marina Kolesnichenko, et al.
The EMBO Journal (2022) Vol. 41, Iss. 21
Open Access | Times Cited: 29
BioE3 identifies specific substrates of ubiquitin E3 ligases
Orhi Barroso‐Gomila, Laura Merino‐Cacho, Veronica Muratore, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 20
Targeting neddylation sensitizes colorectal cancer to topoisomerase I inhibitors by inactivating the DCAF13-CRL4 ubiquitin ligase complex
Yilun Sun, Simone A. Baechler, Xiaohu Zhang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 18
Compartmentalization of the DNA damage response: Mechanisms and functions
Emile Alghoul, Jihane Basbous, Angelos Constantinou
DNA repair (2023) Vol. 128, pp. 103524-103524
Open Access | Times Cited: 17
Nimbolide targets RNF114 to induce the trapping of PARP1 and synthetic lethality in BRCA -mutated cancer
Peng Li, Yuanli Zhen, Chiho Kim, et al.
Science Advances (2023) Vol. 9, Iss. 43
Open Access | Times Cited: 17
Inhibition of topoisomerase 2 catalytic activity impacts the integrity of heterochromatin and repetitive DNA and leads to interlinks between clustered repeats
Michalis Amoiridis, John Verigos, Karen J. Meaburn, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
DNA damage response in breast cancer and its significant role in guiding novel precise therapies
Jiayi Li, Ziqi Jia, Dong Lin, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 7
SUMO and the DNA damage response
Jai S. Bhachoo, Alexander J. Garvin
Biochemical Society Transactions (2024) Vol. 52, Iss. 2, pp. 773-792
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top